| Pack Size/Qty | Price | Unit Price | |
| 90 Tablet/s | $29.00 | $0.33 | |
| 60 Tablet/s | $21.50 | $0.36 | |
| 30 Tablet/s | $12.30 | $0.41 |
Generic Name : Memantine
Brand Name : Namenda
Manufacturer Name : Sun Pharma
Product Code : CRX 255
Delivery Days : 10 to 15 working days
Strength : 5 mg
Packaging : Tablet/s (Blister Packing)
Prescribed For : Headache, Sleepiness, Constipation, Vomiting
Admenta 5mg, also known by its generic name memantine, is a medication primarily prescribed for the treatment of moderate to severe Alzheimer's disease. Alzheimer's disease is a progressive neurological disorder that affects memory, cognition, and the ability to perform daily activities. Admenta belongs to a class of drugs known as N-methyl-D-aspartate (NMDA) receptor antagonists, and it works by modulating the activity of glutamate, a neurotransmitter involved in learning and memory processes.
The underlying pathology of Alzheimer's disease involves the accumulation of abnormal proteins in the brain, leading to the formation of plaques and tangles. These disruptions interfere with normal neuronal communication, contributing to the cognitive decline seen in affected individuals. Admenta exerts its therapeutic effects by blocking the excessive activity of glutamate, which is thought to be a contributing factor in the neurodegenerative processes seen in Alzheimer's disease.
The drug specifically targets the NMDA receptors, which play a crucial role in the regulation of synaptic transmission and plasticity. By modulating the activity of these receptors, Admenta helps maintain a more balanced and controlled glutamatergic neurotransmission, potentially slowing down the progression of cognitive decline in Alzheimer's patients.
Admenta is typically prescribed for individuals diagnosed with moderate to severe Alzheimer's disease. The medication is available in various strengths, and the 5mg dose is often used as part of the titration process. The dosing is typically initiated at a lower strength, and the healthcare provider may gradually increase it based on the patient's response and tolerance.
It is crucial for patients to follow their healthcare provider's instructions regarding the dosage and administration of Admenta. The medication is usually taken orally, with or without food, and the tablets should be swallowed whole.
Numerous clinical studies have investigated the efficacy of Admenta in the treatment of Alzheimer's disease. While it does not cure the condition, it has demonstrated effectiveness in slowing down the progression of cognitive decline and improving overall functioning in some patients.
Admenta's ability to modulate glutamatergic activity makes it a unique player in the field of Alzheimer's therapeutics. It offers an alternative approach to the more commonly prescribed acetylcholinesterase inhibitors, providing healthcare providers with additional options for managing the symptoms of this debilitating disease.
Like any medication, Admenta is associated with potential side effects. Common side effects include dizziness, headache, confusion, and constipation. In some cases, more serious side effects such as hallucinations, chest pain, and difficulty urinating may occur. Patients are advised to report any unusual or severe side effects to their healthcare provider promptly.
Admenta is contraindicated in individuals with a known hypersensitivity to memantine or any of the other ingredients in the formulation. It is essential for healthcare providers to be aware of the patient's medical history, especially if they have a history of seizures, kidney problems, or urinary tract infections.
Caution is also advised when using Admenta in patients with conditions that may increase the risk of developing certain side effects. For example, individuals with a history of heart failure may need close monitoring due to the potential for an increase in blood pressure.
As research in the field of neurodegenerative diseases continues to evolve, there is ongoing interest in exploring new treatment modalities and understanding the underlying mechanisms of Alzheimer's disease. Clinical trials and studies may provide valuable insights into the long-term effects and potential benefits of Admenta, and its role in combination therapies with other Alzheimer's medications may be further explored.
Admenta 5mg represents a valuable addition to the therapeutic options available for the management of moderate to severe Alzheimer's disease. While it does not offer a cure, it has demonstrated efficacy in slowing down cognitive decline and improving overall functioning in some individuals. As with any medication, it is essential for patients to work closely with their healthcare providers to ensure optimal dosing and monitoring for potential side effects. The ongoing research in the field may provide additional insights into the role of Admenta and other medications in the comprehensive care of individuals with Alzheimer's disease.
